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Effect of Cyclooxygenase-2 Glycosylation on Downstream Expression of
E-Cadherin and β-Catenin in MCF-7 Breast Cancer Cells
Genna Roan, Grace Alexander, Klarisse Cruz, Janelle Nguyen, and Mary B. Sevigny
Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA 94901

Cyclooxygenase-2 (COX-2) is an enzyme that helps catalyze the
formation of prostaglandins, which promote inflammation, pain, and
fever and maintain other normal physiological functions throughout
the body1. However, the overexpression of COX-2 has been found
to play a role in various diseases including breast cancer1. COX-2
exists as two major glycoforms— 72 kDa and 74 kDa— due to the
glycosylation site Asn580 which is glycosylated 50% of the time2.
Past studies from our lab have shown that this glycosylation
regulates COX-2 protein turnover in the cell3 (Figure 1). The
proteins E-cadherin— a tumor suppressor— and β-catenin— a
tumor driver— can be regulated by COX-2 activity4.
The purpose of this study is to determine if the glycosylation of
COX-2 at Asn580 affects the downstream expression of Ecadherin and β-catenin and subsequent migratory potential in
MCF-7 breast cancer cells.

EXPERIMENTAL PROCEDURES

Expression levels of E-cadherin and ß-catenin
• Semi-quantitative RT-PCR: Total RNA was isolated from the
transfected MCF-7 cells using TRI Reagent following the
manufacturer’s protocol. After isolation, first strand cDNA was made,
and PCR was carried out using custom primers from IDT to determine
the expression levels of E-cadherin and ß-catenin. ß-actin was used
as a housekeeping gene for normalization.
•

Western blotting: Whole cell lysates prepared from transfected MCF-7
cells were subjected to SDS-PAGE using Bio-Rad Mini-PROTEAN®
TGX™ pre-made gels. Proteins were transferred to a PVDF membrane
using the Bio-Rad Trans-Blot® Turbo™ Blotting system following the
manufacturer's directions. Blots were subjected to immunostaining
using either the anti-E-cadherin monoclonal antibody or the anti-ßcatenin polyclonal rabbit antibody (Santa Cruz Biotechnology). ß-actin
served as a housekeeping protein for normalization (monoclonal
antibody from Sigma).

Effect of COX-2 glycosylation at Asn580 on the Protein Expression of E-cadherin and βcatenin in MCF-7 cells. C = control, MCF-7 cells transfected with empty plasmid; WT = MCF-7 cells
transfected with wild-type COX-2 gene; and M = MCF-7 cells transfected with Asn580-mutant COX-2 gene.
Whole cell lysates were prepared 72 hours after transfection and were subjected to SDS- PAGE followed by
western blotting and immunostaining. β-actin served as the “housekeeping” gene.
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RESULTS

Transfection of cells with the COX-2 gene
The transfection of cells with either the wild-type human COX-2
gene or the Asn580-mutant human COX-2 gene was carried out
using TransIt-LT1 transfection reagent from Mirus Bio. Control cells
were transfected with an empty pcDNA3.1 plasmid from Invitrogen.
Transfection efficiency was confirmed by co-transfection with
pEGFP-1 followed by fluorescent microscopy detection. Expression
of the COX-2 glycoforms was verified via western blots.

Figure 1

Analysis of cell migration
Transfected cells at a density of 5 x 104 cells per well were plated
onto Boyden chambers with 8 µm pore size to test cells’ migratory
potential. Cells were then incubated at 37 °C for 22 hours. After
incubation, cells were fixed in 10% phosphate buffered formalin and
then stained with crystal violet. After drying, the membranes were
viewed under a light microscope using the computer program
MOTIC to view and capture the cell images which were then used to
count how many cells migrated to the underside of the membrane.

Figure 2
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Effect of COX-2 glycosylation on the migratory potential of MCF-7 cells. Control = MCF-7 cells
transfected with empty plasmid; 72/74 kDa = MCF-7 cells transfected with the wild-type COX-2 gene; and
70/72 kDa = MCF-7 cells transfected with the Asn580-mutant COX-2 gene. Seventy-two hours post
transfection, cells were subjected to the cell migration assay. Data are averages +/- SD; n = 2 independent
experiments.

Western blot data showing expression of the COX-2 glycoforms. C = control, COS-1
cells transfected with empty plasmid; WT = COS-1 cells transfected with the wild-type COX-2
gene; MUT = COS-1 cells transfected with the mutant gene.

CONCLUSIONS
• Although there was no significant change in the migratory potential
amongst the three cells groups 72 hours after transfection, E-cadherin
expression decreased at both the transcriptional and translational levels
in the cells that expressed the Asn580-mutant COX-2 gene for 72 hours.
• Transcriptional expression of β-catenin was also reduced 48 and 72
hours post transfection in cells expressing the mutant COX-2 gene.

Asn580

Effect of glycosylation of COX-2 at
on the transcriptional expression of Ecadherin and β-catenin in MCF-7 cells. C = control, MCF-7 cells transfected with empty
plasmid; WT = MCF-7 cells transfected with wild-type COX-2 gene; and M = MCF-7 cells
transfected with Asn580-mutant COX-2 gene. The mRNA expression levels of β-catenin, Ecadherin, COX-2, and β-actin (“housekeeping” gene), were analyzed via RT-PCR at 24 (A), 48
(B), and 72 hours (C) post transfection.

• Since lack of glycosylation at Asn580 leads to an accumulation of COX-2
protein within the cell3, these results indicate that increased levels of
COX-2 correlate with decreased expression of both E-cadherin and βcatenin in the MCF-7 breast cancer cells.
*This work is dedicated to the memory of Dr. Millie Hughes-Fulford, former mentor of M.B.S.*

